Provided by Tiger Trade Technology Pte. Ltd.

Goldman Sachs Holdings

2,402.34
+4.090.17%
Number of Gainers:45
Number of Losers:52
Number of Flat:- -
PE:- -
High:2,408.73
Open:2,398.00
Low:2,394.90
Close:2,398.16
Volume:467.62M
Turnover:101.34B
Market Cap:53.24T
Float Cap:49.84T

Loading ...

Nike Exec - in the Near Term Revenues and Profitability in China Will be Impacted

THOMSON REUTERS
·
Oct 02

Nike Exec - Expect Some Items to Represent a Headwind of Approximately 400 Basis Points to Revenues in the Second Quarter

THOMSON REUTERS
·
Oct 02

Nike Exec on China - We Expect Our Digital Cleanup to Take Multiple Seasons

THOMSON REUTERS
·
Oct 02

Nike Exec on China - Expect Some Actions Will Create Pressure on Reported Revenues for the Remainder of FY27

THOMSON REUTERS
·
Oct 02

Nike CEO says brand performance portfolio continued to grow.

TIPRANKS
·
Oct 02

Nike's Troubles are Mounting, and Sales Could Fall Further

Dow Jones
·
Oct 02

NIKE, Inc. Reports Results for the Quarter Ended August 31 - Earnings Summary

Reuters
·
Oct 02

Nike down 3% at $34.03 after Q1 results and FY27 guidance

TIPRANKS
·
Oct 02

Canada Stocks-TSX Hits 10-Week Low as Mining Shares Fall

Reuters
·
Oct 02

Willis Towers Watson PLC Stock Underperforms Thursday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Oct 02

Nike Announces Q1 Results and Pace Restructuring Plan

TIPRANKS
·
Oct 02

Nike Expects $2.5M in Savings from New Operating Model

Dow Jones
·
Oct 02

Healthcare Stocks Among Top Losers

Dow Jones
·
Oct 02

Primer: Tesla (TSLA US) - Oct 2026

Smartkarma
·
Oct 02

Nike Stock Falls on Disappointing Full-Year Forecast

Dow Jones
·
Oct 02

Elutia Receives $8 Million Payment from Boston Scientific; Company NOW Fully Funded into 2029

THOMSON REUTERS
·
Oct 02

Elutia: Continues to Expect Favorable FDA Clearance Decision for NXT-41X in H1 2027

THOMSON REUTERS
·
Oct 02

Press Release: Elutia Receives $8 Million Payment from Boston Scientific; Company Now Fully Funded into 2029

Dow Jones
·
Oct 02

VWO ETF Falls 0.5%

Dow Jones
·
Oct 02

Bristol Myers Squibb Co. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Oct 02